Plasma Malondialdehyde and Ischemia-modified Albumin levels in breast cancer patients before and after adjuvant chemotherapy

dc.contributor.authorTopcu, T. O.
dc.contributor.authorKavgaci, H.
dc.contributor.authorOzdemir, F.
dc.contributor.authorMentese, A.
dc.contributor.authorOrem, A.
dc.contributor.authorAydin, F.
dc.date.accessioned2025-05-10T19:44:04Z
dc.date.issued2017
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.1016/S0960-9776(17)30162-5
dc.identifier.endpageS44
dc.identifier.issn0960-9776
dc.identifier.issn1532-3080
dc.identifier.scopusqualityQ1
dc.identifier.startpageS44
dc.identifier.urihttps://doi.org/10.1016/S0960-9776(17)30162-5
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10810
dc.identifier.volume32
dc.identifier.wosWOS:000397930400106
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherChurchill Livingstone
dc.relation.ispartofBreast
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titlePlasma Malondialdehyde and Ischemia-modified Albumin levels in breast cancer patients before and after adjuvant chemotherapy
dc.typeConference Object

Dosyalar